- Investing Ideas
- /
- Materials Healthcare Sector
Materials Healthcare Sector
Results
2309
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
2,309 companies
Edgewise Therapeutics
Market Cap: US$1.5b
A biopharmaceutical company, discovers, develops, and commercializes therapies for the treatment of muscle disorders.
EWTX
US$14.45
7D
-1.7%
1Y
-20.5%
Tandem Diabetes Care
Market Cap: US$1.5b
Designs, develops, and commercializes technology solutions for people living with diabetes in the United States and internationally.
TNDM
US$22.70
7D
-0.2%
1Y
-51.6%
Andlauer Healthcare Group
Market Cap: CA$2.1b
A supply chain management company, provides a platform of customized third-party logistics (3PL) and specialized transportation solutions for the healthcare sector in Canada and the United States.
AND
CA$53.48
7D
-0.04%
1Y
31.5%
IDEAYA Biosciences
Market Cap: US$1.5b
A precision medicine oncology company, discovers and develops targeted therapeutics for patient populations selected using molecular diagnostics in the United States.
IDYA
US$17.31
7D
-4.8%
1Y
-58.3%
Regis Healthcare
Market Cap: AU$2.3b
Engages in the provision of residential aged care services in Australia.
REG
AU$7.73
7D
4.0%
1Y
89.5%
Mesoblast
Market Cap: AU$2.2b
Engages in the development of regenerative medicine products in Australia, the United States, Singapore, and Switzerland.
MSB
AU$1.73
7D
1.5%
1Y
59.4%
Ryman Healthcare
Market Cap: NZ$2.4b
Develops, owns, and operates integrated retirement villages, rest homes, and hospitals for the elderly people in New Zealand and Australia.
RYM
NZ$2.45
7D
1.2%
1Y
-37.5%
Immunocore Holdings
Market Cap: US$1.4b
A commercial-stage biotechnology company, engages in the development of immunotherapies for the treatment of cancer, infectious, and autoimmune diseases.
IMCR
US$29.06
7D
-2.5%
1Y
-46.4%
MannKind
Market Cap: US$1.4b
A biopharmaceutical company, focuses on the development and commercialization of therapeutic products and services for endocrine and orphan lung diseases in the United States.
MNKD
US$4.56
7D
-1.5%
1Y
-0.7%
Neogen
Market Cap: US$1.4b
Engages in the development, manufacture, and marketing of various products and services dedicated to food and animal safety worldwide.
NEOG
US$6.56
7D
9.5%
1Y
-51.1%
Adaptive Biotechnologies
Market Cap: US$1.4b
A commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases.
ADPT
US$8.91
7D
-3.9%
1Y
139.5%
Indivior
Market Cap: UK£1.0b
Develops, manufactures, and sells buprenorphine-based prescription drugs for the treatment of opioid dependence and related disorders in the United States, Europe, Canada, Australia, and internationally.
INDV
UK£8.26
7D
-1.9%
1Y
-38.9%
Structure Therapeutics
Market Cap: US$1.4b
A clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States.
GPCR
US$24.43
7D
-8.9%
1Y
-31.9%
Vera Therapeutics
Market Cap: US$1.4b
A clinical stage biotechnology company, focuses on the development and commercialization of transformative treatments for patients with serious immunological diseases.
VERA
US$21.33
7D
-3.2%
1Y
-49.1%
Omnicell
Market Cap: US$1.3b
Provides medication management solutions and adherence tools for healthcare systems and pharmacies the United States and internationally.
OMCL
US$28.08
7D
10.6%
1Y
-11.3%
Sierra Oncology
Market Cap: US$1.3b
Sierra Oncology, Inc., a late-stage biopharmaceutical company, engages in researching, developing, and commercializing therapies for the treatment of patients with hematology and oncology needs.
SRRA
US$54.99
7D
0.06%
1Y
179.4%
Janux Therapeutics
Market Cap: US$1.3b
A clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engager (TRACTr) and Tumor Activated Immunomodulator (TRACIr) platforms technology to treat patients with cancer.
JANX
US$23.27
7D
-11.8%
1Y
-51.0%
Dyne Therapeutics
Market Cap: US$1.3b
A clinical-stage neuromuscular disease company, focuses on discovering and developing therapeutics for neuromuscular diseases in the United States.
DYN
US$11.74
7D
3.9%
1Y
-59.2%
Astrana Health
Market Cap: US$1.3b
A healthcare management company, provides medical care services in the United States.
ASTH
US$27.06
7D
-19.1%
1Y
-34.2%
Green Thumb Industries
Market Cap: CA$1.8b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$7.94
7D
-2.1%
1Y
-55.7%
Heska
Market Cap: US$1.3b
Heska Corporation manufactures and sells diagnostic and specialty products and solutions for veterinary practitioners in the United States, Canada, Mexico, Germany, Italy, Spain, France, Switzerland, Australia, and Malaysia.
HSKA
US$119.99
7D
0.1%
1Y
39.9%
Teladoc Health
Market Cap: US$1.3b
Provides virtual healthcare services worldwide.
TDOC
US$7.25
7D
2.4%
1Y
-43.8%
Celldex Therapeutics
Market Cap: US$1.3b
A biopharmaceutical company, engages in developing therapeutic antibodies for patients with severe inflammatory, allergic, autoimmune, and other diseases.
CLDX
US$20.10
7D
3.0%
1Y
-49.7%
Artivion
Market Cap: US$1.2b
Manufactures, processes, and distributes medical devices and implantable human tissues worldwide.
AORT
US$28.97
7D
1.5%
1Y
23.3%
Azenta
Market Cap: US$1.2b
Provides biological and chemical compound sample exploration and management solutions for the life sciences market in the United States, Africa, China, the United Kingdom, rest of Europe, the Asia Pacific, and internationally.
AZTA
US$26.71
7D
-3.6%
1Y
-48.0%
dentalcorp Holdings
Market Cap: CA$1.7b
Through its subsidiaries, provides health care services by acquiring and partnering with dental practices in Canada.
DNTL
CA$8.53
7D
-2.6%
1Y
32.5%
ANI Pharmaceuticals
Market Cap: US$1.2b
A biopharmaceutical company, develops, manufactures, and markets branded and generic pharmaceutical products in the United States and internationally.
ANIP
US$59.53
7D
-16.8%
1Y
-6.6%
89bio
Market Cap: US$1.2b
A clinical-stage biopharmaceutical company, engages in the development and commercialization of therapies for the treatment of liver and cardio-metabolic diseases.
ETNB
US$7.64
7D
-1.9%
1Y
-14.8%
Pediatrix Medical Group
Market Cap: US$1.2b
Provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States.
MD
US$14.88
7D
3.0%
1Y
91.0%
ARS Pharmaceuticals
Market Cap: US$1.2b
A biopharmaceutical company, develops and commercializes treatments for severe allergic reactions.
SPRY
US$12.20
7D
-9.6%
1Y
34.0%
GRAIL
Market Cap: US$1.2b
A commercial-stage healthcare company, provides multi-cancer early detection testing and services in the United States and internationally.
GRAL
US$38.99
7D
8.0%
1Y
n/a
CVS Group
Market Cap: UK£888.1m
Engages in veterinary, pet crematoria, online pharmacy, and retail businesses.
CVSG
UK£12.38
7D
-3.6%
1Y
20.0%
AdaptHealth
Market Cap: US$1.2b
Distributes home medical equipment (HME), medical supplies, and home and related services in the United States.
AHCO
US$9.04
7D
7.9%
1Y
-8.2%
U.S. Physical Therapy
Market Cap: US$1.2b
Operates and manages outpatient physical therapy clinics.
USPH
US$78.27
7D
10.4%
1Y
-26.3%
Kestra Medical Technologies
Market Cap: US$1.2b
Operates as a wearable medical device and digital healthcare company.
KMTS
US$23.75
7D
4.9%
1Y
n/a
Sienna Senior Living
Market Cap: CA$1.6b
Provides senior living services in Canada.
SIA
CA$17.60
7D
2.0%
1Y
20.5%